More than a hundred thousand women diagnosed with breast cancer in Europe and the US each year could avoid chemotherapy by taking a gene test made by Agendia, a Dutch biotech group, which can attempt to predict whether the disease is likely to return.
通過接受一家荷蘭生物科技集團Agendia開發的一項基因測試，每年確診患有乳腺癌的逾10萬名歐美女性可能不必接受化療。Agendia可以嘗試預測癌癥有無復發可能。
您已閱讀12%（332字），剩余88%（2487字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。